| 1 |
34249417 | A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers. | 2021 |
1 |
| 2 |
34873494 | Erratum: A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers. | 2021 |
1 |
| 3 |
29496164 | Dietary isoflavone daidzein synergizes centchroman action via induction of apoptosis and inhibition of PI3K/Akt pathway in MCF-7/MDA MB-231 human breast cancer cells. | 2018 Feb 1 |
1 |
| 4 |
29761845 | The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation. | 2018 Sep |
1 |
| 5 |
23272911 | Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment. | 2013 Sep |
2 |
| 6 |
22412975 | Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis. | 2012 |
1 |
| 7 |
20107864 | A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer. | 2011 Aug |
1 |
| 8 |
21161820 | Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. | 2011 |
1 |
| 9 |
22200028 | Induction of cancer cell death by isoflavone: the role of multiple signaling pathways. | 2011 Oct |
1 |
| 10 |
20177775 | Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells. | 2010 Jul |
2 |
| 11 |
19472400 | NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway. | 2009 Jul 15 |
1 |
| 12 |
18687691 | Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. | 2008 Oct 10 |
3 |
| 13 |
16840783 | The isoflavone Equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. | 2006 Sep 15 |
2 |